Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach

被引：12
|
作者：
Obando-Pereda, Gustavo [1 ]
机构：
[1] Univ Catolica Santa Maria, Prote Inflammat & Pain Lab, Urb San Jose S-N, Arequipa 04001, Peru
来源：
JOURNAL OF MEDICAL VIROLOGY | 2021年 / 93卷 / 09期
关键词：
cytokine storm; macrophage; molecular mimicry; SARS-CoV-2; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; MACROPHAGE ACTIVATION; CD8(+) T; COVID-19; PROTEIN; PARP14; SEQUENCE; PEPTIDE;
D O I：
10.1002/jmv.27040
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
PARP14 and PARP9 play a key role in macrophage immune regulation. SARS-CoV-2 is an emerging viral disease that triggers hyper-inflammation known as a cytokine storm. In this study, using in silico tools, we hypothesize about the immunological phenomena of molecular mimicry between SARS-CoV-2 Nsp3 and the human PARP14 and PARP9. The results showed an epitope of SARS-CoV-2 Nsp3 protein that contains consensus sequences for both human PARP14 and PARP9 that are antigens for MHC Classes 1 and 2, which can potentially induce an immune response against human PARP14 and PARP9; while its depletion causes a hyper-inflammatory state in SARS-CoV-2 patients.
引用
收藏
页码：5350 / 5357
页数：8
相关论文
共 50 条
  • [21] Molecular mimicry between SARS-CoV-2 and the female reproductive system
    Dotan, Arad
    Kanduc, Darja
    Muller, Sylviane
    Makatsariya, Alexander
    Shoenfeld, Yehuda
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2021, 86 (06)
  • [22] Guillain-Barre syndrome, SARS-CoV-2 and molecular mimicry
    Lucchese, Guglielmo
    Floeel, Agnes
    BRAIN, 2021, 144
  • [23] Molecular mimicry of SARS-COV-2 antigens with tumor associated antigens
    Ragone, Concetta
    Mauriello, Angela
    Cavalluzzo, Beatrice
    Cavalcanti, Ernesta
    Russo, Luigi
    Mangano, Simona
    Cembrola, Biancamaria
    Tagliamonte, Maria
    Buonaguro, Luigi
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [24] SARS-CoV-2: a storm is raging
    Pedersen, Savannah F.
    Ho, Ya-Chi
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05): : 2202 - 2205
  • [25] Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
    Rolta, Rajan
    Salaria, Deeksha
    Sharma, Bhanu
    Awofisayo, Oladoja
    Fadare, Olatomide A.
    Sharma, Sonum
    Patel, Chirag N.
    Kumar, Vikas
    Sourirajan, Anuradha
    Baumler, David J.
    Dev, Kamal
    CURRENT PHARMACOLOGY REPORTS, 2022, 8 (02) : 149 - 170
  • [26] Cytokine storm and colchicine potential role in fighting SARS-CoV-2 pneumonia
    Vitiello, Antonio
    Ferrara, Francesco
    Pelliccia, Chiara
    Granata, Giovanni
    La Porta, Raffaele
    ITALIAN JOURNAL OF MEDICINE, 2020, 14 (02) : 88 - 94
  • [27] Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
    Kulanthaivel, Shanmugaraj
    Kaliberdenko, Vitalii B.
    Balasundaram, Keerthanaa
    Shterenshis, Michael, V
    Scarpellini, Emidio
    Abenavoli, Ludovico
    REVIEWS ON RECENT CLINICAL TRIALS, 2021, 16 (02) : 138 - 145
  • [28] Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
    Rabiu Abubakar, Abdullahi
    Ahmad, Rahnuma
    Rowaiye, Adekunle Babajide
    Rahman, Sayeeda
    Iskandar, Katia
    Dutta, Siddhartha
    Oli, Angus Nnamdi
    Dhingra, Sameer
    Tor, Maryam Abba
    Etando, Ayukafangha
    Kumar, Santosh
    Irfan, Mohammed
    Gowere, Marshall
    Chowdhury, Kona
    Akter, Farhana
    Jahan, Dilshad
    Schellack, Natalie
    Haque, Mainul
    LIFE-BASEL, 2022, 12 (04):
  • [29] Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection
    Lipworth, Brian
    Chan, Rory
    Lipworth, Samuel
    Kuo, Chris RuiWen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (06): : 1798 - 1801
  • [30] In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor
    Khan, Faez Iqbal
    Hassan, Fakhrul
    Lai, Dakun
    FRONTIERS IN IMMUNOLOGY, 2022, 12
12345